Evaluates how whey dangke supplementation alters lipid metabolism in Friesian Holstein calves, indicating potential dietary benefits.
Effective feed management in dairy calves is essential for their performance as high-quality replacement stock. To support optimal growth, calf starters must possess high nutritional value and digestibility. Enhancing the digestibility of calf starter feed can be achieved by including whey dangke, a by-product known for its high protein digestibility. These lipid parameters are vital for growth, including tissue development and as precursors for various growth-related hormones. Therefore, this study aims to evaluate the concentrations of triglycerides, HDL, LDL, and cholesterol in response to dietary supplementation with whey dangke. A completely randomized design was employed, with three treatment groups and six replicates per group. The treatments involved levels of whey dangke supplementation: T0 (0% of body weight), T1 (2.5%), and T2 (5%). A total of 18 Friesian Holstein dairy calves aged 2-3 months were used in the experiment. The findings demonstrated that whey dangke supplementation significantly affected (P<0.05) blood cholesterol and triglyceride concentrations. As the supplementation level increased, both cholesterol and triglyceride levels decreased, yet remained within normal physiological ranges. Significantly, supplementation up to 5% did not disrupt blood lipid profiles, indicating that whey dangke is safe and does not induce adverse health effects in dairy calves.
No takes yet. Share an insight, caveat, or question.
Ramadan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: